Previous work has shown that mammalian cells that carry unstably amplified genes for dihydrofolate reductase (DHFR) gradually lose the amplified DHFR genes when grown in the absence of the DHFR inhibitor methotrexate (MTX). Unstably amplified genes occur on small acentric chromosomes called double minutes (DMs) or even smaller chromatin fragments, in contrast to stably amplified genes, which reside in centromere-containing chromosomes. We have found that the rate of loss of the unstably amplified DHFR genes can be greatly increased by growing the cells in the presence of a nonlethal concentration of hydroxyurea. For example, in one MTX-resistant subline studied, approximate to 90% of the original DHFR gene dosage is lost in 25-30 cell doubl...
Gene amplification is frequently observed in tumors and transformed cell lines. This phenomenon is k...
Gene amplification, a key mechanism for oncogene activation and drug resistance in tumour cells, inv...
Gene amplification, a key mechanism for oncogene activation and drug resistance in tumour cells, inv...
We discuss our recent findings in three related areas of the gene amplification field. 1) We have fo...
Gene amplification may be visualized within a chromosome as a homogeneously stained region (HSR) and...
Gene amplification may be visualized within a chromosome as a homogeneously stained region (HSR) and...
AbstractSite-directed mutagenesis was used to generate mutants of mouse dihydrofolate reductase more...
Several variants resistant to 1.8 x 10(-4) M DL-methotrexate (MTX) have been isolated from the human...
The analysis of several derivatives of the human cell lines HeLa and VA2-B, selected for resistance ...
Previous work has shown that the presence of a phorbol ester tumor promoter, phorbol 12-myristate 13...
Dihydrofolate reductase (DHFR; EC 1.5.1.3) is required in folate metabolism for the synthesis of pur...
Dihydrofolate reductase (DHFR; EC 1.5.1.3) is required in folate metabolism for the synthesis of pur...
Mammalian gene amplification has been studied using as a model system the amplification of the endog...
Submicroscopic extrachromosomal elements (amplisomes) containing amplified dihydrofolate reductase (...
We have transferred a mutant hamster gene coding for an altered dihydrofolate reductase to wild-type...
Gene amplification is frequently observed in tumors and transformed cell lines. This phenomenon is k...
Gene amplification, a key mechanism for oncogene activation and drug resistance in tumour cells, inv...
Gene amplification, a key mechanism for oncogene activation and drug resistance in tumour cells, inv...
We discuss our recent findings in three related areas of the gene amplification field. 1) We have fo...
Gene amplification may be visualized within a chromosome as a homogeneously stained region (HSR) and...
Gene amplification may be visualized within a chromosome as a homogeneously stained region (HSR) and...
AbstractSite-directed mutagenesis was used to generate mutants of mouse dihydrofolate reductase more...
Several variants resistant to 1.8 x 10(-4) M DL-methotrexate (MTX) have been isolated from the human...
The analysis of several derivatives of the human cell lines HeLa and VA2-B, selected for resistance ...
Previous work has shown that the presence of a phorbol ester tumor promoter, phorbol 12-myristate 13...
Dihydrofolate reductase (DHFR; EC 1.5.1.3) is required in folate metabolism for the synthesis of pur...
Dihydrofolate reductase (DHFR; EC 1.5.1.3) is required in folate metabolism for the synthesis of pur...
Mammalian gene amplification has been studied using as a model system the amplification of the endog...
Submicroscopic extrachromosomal elements (amplisomes) containing amplified dihydrofolate reductase (...
We have transferred a mutant hamster gene coding for an altered dihydrofolate reductase to wild-type...
Gene amplification is frequently observed in tumors and transformed cell lines. This phenomenon is k...
Gene amplification, a key mechanism for oncogene activation and drug resistance in tumour cells, inv...
Gene amplification, a key mechanism for oncogene activation and drug resistance in tumour cells, inv...